-
Uncategorized2 weeks ago
Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails
BMS is barreling toward a clinical trial readout that an H.C. Wainwright analyst believes could contribute to the return of mergers between mega-cap drugmakers.
-
Uncategorized2 weeks ago
The physicochemical design, structure and permeability of the JCVI-syn3A minimal cell membrane
Post Content
-
AI, Machine Learning & Computational Biology2 weeks agoSTAT+: ADA review of members’ expulsion denies group censored opinions, called in police
STAT+: ADA review of members’ expulsion denies group censored opinions, called in police
-
AI, Machine Learning & Computational Biology2 weeks agoOpinion: Diabetes association CEO: What an independent review says happened at the ADA’s controversial June conference
Opinion: Diabetes association CEO: What an independent review says happened at the ADA’s controversial June conference
-
Uncategorized2 weeks ago
Single-Cell Striatum Atlas Reveals Neurological Disorder Vulnerabilities
The striatum, a brain region involved in movement, decision-making, habit formation, and reward processing, is also implicated in some of the most difficult-to-treat neurological and psychiatric...
-
Uncategorized2 weeks ago
Advanced Imaging Technique Reveals Immune Cell Metabolic States in Blood Samples
Advanced Imaging Technique Reveals Immune Cell Metabolic States in Blood Samples
-
AI, Machine Learning & Computational Biology2 weeks agoSTAT+: House votes to temporarily block Trump plan to politicize federal grants
STAT+: House votes to temporarily block Trump plan to politicize federal grants
-
AI, Machine Learning & Computational Biology2 weeks agoOpinion: I’m a reproductive psychiatrist. The Lindsay Clancy trial will cause terrible damage to my field
Opinion: I’m a reproductive psychiatrist. The Lindsay Clancy trial will cause terrible damage to my field
-
Uncategorized2 weeks agoMid-cap biotechs join Trump’s latest round of drug pricing deals
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to meaningfully impact drugmaker profits.
-
Capital, M&A & Industry Strategy2 weeks ago
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
Roche has tapped Simcere Zaiming for a new T cell engager that could have broad application in B cell–mediated diseases including lymphoma and autoimmune conditions.
Ensuring safety and accountability in China’s biomedical translation system
Blood centers can help biopharma scale cell and gene therapies
Psychedelics at FDA, Mike Davis’ CDER and translating tRNAs — a BioCentury podcast
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
